Rare Thyroid Therapeutics
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Klara Norra Kyrkogata 26, Stockholm, Sto...Phone Number
+46 86579600Website
www.rarethyroid.comRevenue
<$5 MillionIndustry
About Rare Thyroid Therapeutics
Is Rare Thyroid Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Rare Thyroid Therapeutics is spiking on competitors!
Rare Thyroid Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Rare Thyroid Therapeutics has new funding data
Check if Rare Thyroid Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Rare Thyroid Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Rare Thyroid Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rare Thyroid Therapeutics launches new products
Click to see if Rare Thyroid Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Rare Thyroid Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Rare Thyroid Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rare Thyroid Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rare Thyroid Therapeutics.
Rare Thyroid Therapeutics Tech Stack
A closer look at the technologies used by Rare Thyroid Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rare Thyroid Therapeutics
Egetis Therapeutics is an innovative pharmaceutical company specializing in the late-stage development of treatments for serious diseases with significant unmet medical needs, particularly in the orphan drug segment. Their key products include Emcitate, aimed at treating MCT8 deficiency, and Aladote, which addresses paracetamol overdosing. The comp... Read More